National Heart, Lung, and Blood Institute (NHLBI): Death, Sudden, Cardiac trials
The registry lists 14 Death, Sudden, Cardiac studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 3 8No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or VenetoclaxRecruitingNCT05724121
- Home Use of Automatic External Defibrillators to Treat Sudden Cardiac ArrestCompletedNCT00047411Phase 3
- Anxiety and Vagal Control of the Heart in Coronary DiseaseCompletedNCT00006311
- Epidemiology of Cardiotoxicity in Children With CancerCompletedNCT00005418
- Novel Hemostatic Cardiac Risk Factors in FraminghamCompletedNCT00005356
- Natural History of Coronary Heart DiseaseCompletedNCT00005265
- Identifying High Risk Patients With SyncopeCompletedNCT00005202
- Public Access Defibrillation (PAD) Community TrialCompletedNCT00004560Phase 3
- Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)CompletedNCT00000609Phase 3
- Coronary Artery Bypass Graft (CABG) Patch TrialCompletedNCT00000540Phase 3
- Antiarrhythmics Versus Implantable Defibrillators (AVID)CompletedNCT00000531Phase 3
- Cardiac Arrhythmia Suppression Trial (CAST)CompletedNCT00000526Phase 3
- Beta-Blocker Heart Attack Trial (BHAT)CompletedNCT00000492Phase 3
- Multicenter Unsustained Tachycardia Trial (MUSTT)CompletedNCT00000480Phase 3